Press Releases

POWYS, UK - Mar 5, 2014 - Commercial packaging and clinical trial services specialist Packaging Coordinators, Inc. (PCI) is pleased to announce the introduction of refrigerated GMP packaging facilities for temperature controlled pharmaceuticals at its facilities in the UK.

It is widely recognized that more and more temperature sensitive investigational drug product has limited stability data available and as such there is an increasing need for projects to be labelled and packed within a refrigerated environment to maintain the drugs' efficacy.

PCI is focussed on the rapidly changing needs of the Clinical Trial industry and responding to increased customer demand for specialized temperature controlled packaging and has introduced a dedicated capability for 2-8 °C packaging at its site in Hay on Wye.

"The safety of our customers' product is of upmost importance to us" stated Tim Roberts, Associate Director of Clinical Services, "By introducing this additional service, we will not only be able to ensure the safety and integrity of our customers' products, we will help make significant efficiencies to their packaging lead times of temperature sensitive material."

PCI has invested significantly in supporting Cold Chain logistics for packaging both investigational as well as commercial medicinal products in a variety of drug delivery forms, including oral solids and parenteral delivery forms such as injectable and transdermal.  PCI's global network of 14 locations features designated sites with specialized capabilities such as Cold Chain packaging, in addition to significant on-site Cold Chain storage at 2-8°C, -20°C, -40oC and -80°C.  PCI also supports controlled temperature shipments to worldwide investigational sites through its logistics network, which includes the recently announced construction of a new Storage and Distribution site for investigational medicines in North America slated to open in August of this year.

About PCI
The global healthcare industry trusts PCI for the packaging solutions that increase their products' speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global packaging needs throughout the product life cycle - from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients' lives.  For more information please visit www.pciservices.com or follow us on Twitter at @PCI_Social.